Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?

Author:

Menzella Francesco1ORCID,Latorre Manuela2,Ruggiero Patrizia1,Bagnasco Diego3,Heffler Enrico4ORCID

Affiliation:

1. Department of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy

2. Department of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Pisa, Italy

3. Allergy & Respiratory Diseases, DIMI Department of Internal Medicine, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy

4. Personalized Medicine, Asthma and Allergy, Humanitas Research Hospital, Rozzano, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Reference51 articles.

1. Asthma

2. Asthma

3. Global Initiative For Asthma. Global strategy for asthma management and prevention; [cited 2018 December 22]. Available from: http://ginasthma.org.

4. Asthma Endotypes and an Overview of Targeted Therapy for Asthma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3